Emerging Trends in Nanotechnology for Endometriosis: Diagnosis to Therapy
Nanomaterials · 05.06.2024 · 14 (11) · 976
DOI: 10.3390/nano14110976 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanomaterials, online erschienen am 05.06.2024. Verfasst von Souvanik Talukdar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA 30310, USA. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health, National Cancer Institute.
Abstract (Originalsprache)
Endometriosis, an incurable gynecological disease that causes abnormal growth of uterine-like tissue outside the uterine cavity, leads to pelvic pain and infertility in millions of individuals. Endometriosis can be treated with medicine and surgery, but recurrence and comorbidities impair quality of life. In recent years, nanoparticle (NP)-based therapy has drawn global attention, notably in medicine. Studies have shown that NPs could revolutionize conventional therapeutics and imaging. Researchers aim to enhance the prognosis of endometriosis patients with less invasive and more effective NP-based treatments. This study evaluates this potential paradigm shift in endometriosis management, exploring NP-based systems for improved treatments and diagnostics. Insights into nanotechnology applications, including gene therapy, photothermal therapy, immunotherapy, and magnetic hyperthermia, offering a theoretical reference for the clinical use of nanotechnology in endometriosis treatment, are discussed in this review.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA 30310, USA.
- Cancer Biology Research and Training, Department of Biological Sciences, Alabama State University, Montgomery, AL 36104, USA.
- Cancer Health Equity Institute, Morehouse School of Medicine, Atlanta, GA 30310, USA.
ORCID-Profile: Santosh K Singh, Manoj K Mishra, Rajesh Singh
Förderung
- NCI NIH HHS
- National Institutes of Health
- National Cancer Institute
- American Cancer Society
- Department of Defense
Zitieren
APA
Talukdar, S., Singh, S. K., Mishra, M. K., & Singh, R. (2024). Emerging Trends in Nanotechnology for Endometriosis: Diagnosis to Therapy. Nanomaterials, 14(11), 976. https://doi.org/10.3390/nano14110976
Vancouver
Talukdar S, Singh SK, Mishra MK, Singh R. Emerging Trends in Nanotechnology for Endometriosis: Diagnosis to Therapy. Nanomaterials. 2024;14(11):976. doi:10.3390/nano14110976
BibTeX
@article{Talukdar2024,
author = {Talukdar, Souvanik and Singh, Santosh K and Mishra, Manoj K and Singh, Rajesh},
title = {Emerging Trends in Nanotechnology for Endometriosis: Diagnosis to Therapy},
journal = {Nanomaterials},
year = {2024},
volume = {14},
number = {11},
pages = {976},
doi = {10.3390/nano14110976}
}
EUVIMED